Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease

Table 1

Clinical characteristicof 252 CKD patients.

	All patients ()
Male (%)	59.1
Age (years)	67 (60–75)
Diabetes (%)	35.7
Smoking (%)	37.9
Systolic BP (mmHg)	130 (122–142)
BMI (kg/m^2)	22.3 (20.2–24.7)
CKD grade (%)
G3a	25.4
G3b	14.7
G4	35.7
G5	24.2
Plasma NGAL (ng/mL)	105 (60–194)
Urinary NGAL (μg/gCr)	65 (15–235)
BNP (pg/mL)	30 (17–71)
eGFR (mL/min/1.73 m^2)	25.1 (15.2–38.5)
Hemoglobin (g/dL)	11.3 (9.8–12.7)
hsCRP (mg/L)	0.6 (0.2–1.5)
UACR (mg/gCr)	338 (102–1321)
TG (mg/dL)	137 (103–193)
LDL-C (mg/dL)	109 (87–129)
HDL-C (mg/dL)	54 (44–68)
ECG
LVH (%)	6.1
ST-T change (%)	9.8
EF (%) by UCG	60.0 (57.0–64.0)
ARB or ACEi (%)	71.0
Statins (%)	29.8

; .
ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BP, blood pressure; BMI, body mass index; BNP, B-type natriuretic peptide; ECG, electrocardiogram; CKD, chronic kidney disease; EF, ejection fraction; eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein-cholesterol; hsCRP, high-sensitivity C-reactive protein; LDL-C, low-density lipoprotein-cholesterol; LVH, left ventricular hypertrophy; NGAL, neutrophil gelatinase-associated lipocalin; TG, triglyceride; UACR, urinary albumin creatinine ratio; UCG, ultracardiography.